225 related articles for article (PubMed ID: 15217536)
21. A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box.
Hanada T; Yoshida T; Kinjyo I; Minoguchi S; Yasukawa H; Kato S; Mimata H; Nomura Y; Seki Y; Kubo M; Yoshimura A
J Biol Chem; 2001 Nov; 276(44):40746-54. PubMed ID: 11522790
[TBL] [Abstract][Full Text] [Related]
22. JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3.
Yadav A; Kalita A; Dhillon S; Banerjee K
J Biol Chem; 2005 Sep; 280(36):31830-40. PubMed ID: 15998644
[TBL] [Abstract][Full Text] [Related]
23. SOCS proteins: negative regulators of cytokine signaling.
Krebs DL; Hilton DJ
Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
[TBL] [Abstract][Full Text] [Related]
24. Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro.
Leong GM; Moverare S; Brce J; Doyle N; Sjögren K; Dahlman-Wright K; Gustafsson JA; Ho KK; Ohlsson C; Leung KC
Endocrinology; 2004 Dec; 145(12):5525-31. PubMed ID: 15319356
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
26. A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.
Flowers LO; Subramaniam PS; Johnson HM
Oncogene; 2005 Mar; 24(12):2114-20. PubMed ID: 15688010
[TBL] [Abstract][Full Text] [Related]
27. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
Auernhammer CJ; Isele NB; Kopp FB; Spoettl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901
[TBL] [Abstract][Full Text] [Related]
28. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.
Dif F; Saunier E; Demeneix B; Kelly PA; Edery M
Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells.
Lin YC; Lin CK; Tsai YH; Weng HH; Li YC; You L; Chen JK; Jablons DM; Yang CT
Oncol Rep; 2010 Dec; 24(6):1605-12. PubMed ID: 21042758
[TBL] [Abstract][Full Text] [Related]
30. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway.
Cooney RN
Shock; 2002 Feb; 17(2):83-90. PubMed ID: 11837794
[TBL] [Abstract][Full Text] [Related]
31. Analysis of SOCS-3 promoter responses to interferon gamma.
Gatto L; Berlato C; Poli V; Tininini S; Kinjyo I; Yoshimura A; Cassatella MA; Bazzoni F
J Biol Chem; 2004 Apr; 279(14):13746-54. PubMed ID: 14742442
[TBL] [Abstract][Full Text] [Related]
32. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE
Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843
[TBL] [Abstract][Full Text] [Related]
33. [Effects of transfected SOCS3 gene on proliferation of human lung adenocarcinoma cell line A549].
Yu ZB; Min JX; Bai L; Yao K; Zhang GQ
Ai Zheng; 2004 Sep; 23(9):1047-51. PubMed ID: 15363199
[TBL] [Abstract][Full Text] [Related]
34. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma.
Oshimo Y; Kuraoka K; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Cancer; 2004 Dec; 112(6):1003-9. PubMed ID: 15386345
[TBL] [Abstract][Full Text] [Related]
36. The effect of suppressor of cytokine signaling 3 on GH signaling in beta-cells.
Rønn SG; Hansen JA; Lindberg K; Karlsen AE; Billestrup N
Mol Endocrinol; 2002 Sep; 16(9):2124-34. PubMed ID: 12198248
[TBL] [Abstract][Full Text] [Related]
37. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.
Cacalano NA; Sanden D; Johnston JA
Nat Cell Biol; 2001 May; 3(5):460-5. PubMed ID: 11331873
[TBL] [Abstract][Full Text] [Related]
38. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA
EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194
[TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatory roles of retinoic acid in rat brain astrocytes: Suppression of interferon-gamma-induced JAK/STAT phosphorylation.
Choi WH; Ji KA; Jeon SB; Yang MS; Kim H; Min KJ; Shong M; Jou I; Joe EH
Biochem Biophys Res Commun; 2005 Apr; 329(1):125-31. PubMed ID: 15721283
[TBL] [Abstract][Full Text] [Related]
40. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]